Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 811 | 2,448 | 4,049 | 5,485 | 6,575 |
| TOTAL | $1,143 | $2,815 | $4,075 | $5,653 | $7,268 |
| Non-Current Assets | |||||
| PPE Net | N/A | 138 | 138 | 156 | 158 |
| Other Non-Current Assets | 2,269 | 2,921 | 2,995 | 3,886 | 3,998 |
| TOTAL | $2,269 | $3,059 | $3,133 | $4,042 | $4,156 |
| Total Assets | $3,412 | $5,874 | $7,208 | $9,695 | $11,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 845 | 712 | 315 | 80 | 167 |
| Accrued Expenses | 504 | 694 | 452 | 564 | 795 |
| TOTAL | $1,350 | $2,126 | $1,463 | $1,495 | $1,784 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 464 | 653 | 1,472 | 1,697 |
| TOTAL | $262 | $726 | $915 | $1,740 | $1,965 |
| Total Liabilities | $1,612 | $2,852 | $2,378 | $3,235 | $3,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,693 | 6,406 | 6,406 | 6,406 | 5,087 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -214,034 | -212,708 | -210,787 | -208,875 | -206,725 |
| TOTAL | $1,800 | $3,022 | $4,830 | $6,460 | $7,675 |
| Total Liabilities And Equity | $3,412 | $5,874 | $7,208 | $9,695 | $11,424 |